BrainsWay (NASDAQ:BWAY – Get Rating) and INVO Bioscience (NASDAQ:INVO – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations. Valuation and Earnings This table compares BrainsWay and INVO Bioscience’s […]
BrainsWay (NASDAQ:BWAY – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company’s […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Equities research analysts expect BrainsWay Ltd. (NASDAQ:BWAY – Get Rating) to post sales of $7.45 million for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for BrainsWay’s earnings, with the lowest sales estimate coming in at $7.20 million and the highest estimate coming in at $7.70 million. BrainsWay posted sales of $6.12 […]